Cell cycle checkpoint control: The cyclin G1/Mdm2/p53 axis emerges as a strategic target for broad-spectrum cancer gene therapy - A review of molecular mechanisms for oncologists

por Gordon, Erlinda M., Ravicz, Joshua R., Liu, Seiya, Chawla, Sant P., Hall, Frederick L.
Publicado 2018